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Acute lymphoblastic leukemia (ALL) is the most common
cancer during childhood. Nevertheless, in recent years there
have been marked improvements in treatment and conse-
quent survival.There are a number of patients that experience
relapses and patients that cannot be cured. In this special
issue different aspects relating to factors influencing the best
response to treatment are described.M. Czogała et al. showed
that plasma ammonia concentration reflexes L-asparaginase
activity may be a useful tool for assessing treatment in
children with ALL. In another study A. Medina-Sanson et
al. identified the importance of a genetic polymorphism of
deoxycytidine kinase and cytidine deaminase in assessing
the toxicity by cytarabine in children with acute myeloid
leukemia and found that this polymorphism might predict
death in affected children.
A. Vilchis-Ordon˜ez et al. addressed a very interesting
topic about subpopulations of leukemic cells that contribute
to a proinflammatory microenvironment within B-ALL bone
marrow that may cause a delay in the normal hematopoiesis.
Two studies assessed the participation of environmental
risk factors in the development of acute leukemia.A.Morales-
Sa´nchez et al. did not find that EBV, HCMV, HHV6, and
HHV7were related to the development of ALL. Furthermore,
J. D. Ferreira et al. did not show that maternal alcohol con-
sumption during pregnancy was associated with leukemia in
young children.
Finally a study by V. C. Bekker-Me´ndez et al. demon-
strated differences in the frequency of gene rearrangement
between the Mexican population and populations from
developed countries.
From these articles it is clear that throughout the world
the survival of children with acute leukemia is a great
concern, especially in less developed countries. It is very
important to search for factors associated with treatment
compliance in children and those factors that may be related
to treatment response.
The microenvironment in the leukemic bone marrow is
a very important factor in the etiology of acute leukemia.
Recovery of the bone marrow during treatment is also very
important and further studies are needed to address this
important aspect.
The environmental etiology of acute leukemia is a chal-
lenge that still has not been resolved. To identify environ-
mental risk factors is not easy. It is important to identify both
the environmental risk factors and also the gene-environment
interactions that increase the susceptibility to development of
leukemia.
The presentation of acute kinds of leukemia in Hispanic
children is different from other populations; notably clinical
features, the age incidence peak, and molecular factors are
different.
In this special issue the complexity of the molecular and
clinical epidemiology of acute leukemia in children has been
shown. There are countries where success has been clearly
demonstrated, but in other countries this is not apparent.
This disease kills more children in developed countries and
some emerging economies. There is a need to strengthen
the research groups that are working to identify the factors
that affect the adherence to treatment and the response to
treatment. However, there is also a need for integration with
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those research groups that are working on the etiology of
leukemia, especially including epidemiology and cellular and
molecular biology.
We need to understand more about leukemia, in order
to be able to cure and prevent it. The challenge continues
because it is not a dream to think that one day almost all kinds
of leukemia in children could be cured and that one day this
disease could be prevented.
Juan Manuel Mej´ıa-Arangure´
Richard J. Q. McNally
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
